Factor | Unadjusted analysis | Adjusted analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95Â % CI | p-value | Hazard ratio | 95Â % CI | p-value | |
Sex | Â | Â | 0.012 | Â | Â | 0.930 |
Male | 1 (ref) | Â | Â | 1 (ref) | Â | Â |
Female | 0.80 | 0.67–0.95 |  | 0.99 | 0.83–1.19 |  |
Age at enrolment | Â | Â | 0.259 | Â | Â | 0.996 |
15–34 | 1 (ref) |  |  | 1 (ref) |  |  |
≥35 | 1.11 | 0.93–1.32 |  | 1.00 | 0.83–1.20 |  |
CD4 count (cells/μL) at enrolment |  |  | <0.001 |  |  | <0.001 |
≤250 | 1 (ref) |  |  | 1 (ref) |  |  |
251–350 | 0.36 | 0.28–0.47 |  | 0.35 | 0.27–0.46 |  |
351–500 | 0.18 | 0.13–0.25 |  | 0.17 | 0.13–0.24 |  |
>500 | 0.12 | 0.09–0.16 |  | 0.12 | 0.09–0.17 |  |
Missing | 0.71 | 0.40–1.27 |  | 0.74 | 0.41–1.33 |  |
Year of enrolment | Â | Â | 0.002 | Â | Â | <0.001 |
2008 | 1 (ref) | Â | Â | 1 (ref) | Â | Â |
2009 | 0.69 | 0.56–0.86 |  | 0.62 | 0.49–0.77 |  |
2010 | 0.89 | 0.71–1.11 |  | 0.74 | 0.59–0.93 |  |
2011 | 0.66 | 0.48–0.91 |  | 0.60 | 0.44–0.83 |  |
Route of HIV testing | Â | Â | <0.001 | Â | Â | 0.009 |
CRH | 1 (ref) | Â | Â | 1 (ref) | Â | Â |
HIV serosurvey | 0.71 | 0.59–0.85 |  | 0.75 | 0.62–0.91 |  |
Missing | 1.04 | 0.77–1.41 |  | 1.01 | 0.74–1.38 |  |